TENX
$1.26
Tenax Therapeutics
($.03)
(2.33%)
TENX
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.15)
Revenue:  $0.00 Mil
Tuesday
Feb 15
8:30 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when TENX reports earnings?
Beat
Meet
Miss

Where is TENX's stock price going from here?
Up
Flat
Down
Stock chart of TENX
Analysts
Summary of analysts' recommendations for TENX
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Tenax Therapeutics, Inc. is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market. The Company specializes in creating pharmaceuticals and medical devices in the fields of oxygen therapeutics, blood substitutes, and liquid ventilation and implanted glucose sensing. Tenax Therapeutics Inc., formerly known as Oxygen Biotherapeutics, Inc., is based in United States.
Peers
IncyteExelixisExact SciencesCharles River Laboratories InternationalCoherus Biosciences